Reinsurance Group of America, Incorporated · RZC · FY2025 Q3 · Calendar Q4 2025
RGA posts strong Q3 operating results and maintains guidance
The supplied analysis supports a constructive operating thesis: premium growth, the Equitable transaction, in-force margin gains and substantial capital support earnings momentum. That view is tempered by claims volatility, repricing headwinds, investment-income variability and uncertainty around mortality assumptions; prior-quarter comparisons and consensus benchmarks are unavailable.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about RZC FY2025 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The Equitable block closed and contributed a full quarter of earnings. Management highlighted new product launches, progress on in-force actions and the Ruby Re sidecar, while maintaining guidance.
Guidance delta
Management maintained guidance; no quantitative change was supplied.
Key takeaways
- Management reported record operating EPS of $6.37 per share.
- Premiums grew 8.5% year to date, led by Asia, EMEA and U.S. Financial Solutions.
- The Equitable block closed and is expected to add $70 million of pretax income in 2025, scaling to $200 million by 2027.
- Management cited $2.3 billion of excess capital and $3.4 billion of deployable capital, with share repurchases completed.
- In-force business margins rose 16% over three quarters, supporting management's view of improved long-term earnings power.
Management priorities
- Continue deploying capital into new business and in-force transactions.
- Fully deploy the Ruby Re sidecar by mid-2026 and explore additional sidecars.
- Maintain share repurchases and dividend payouts as excess capital permits.
- Expand product innovation in critical illness and cancer treatment lines.
- Pursue high-return opportunities while preserving balance-sheet strength.
Follow RZC with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeCompany context
Snapshot as of publicationReinsurance Group of America, Inc. functions as a holding company, concentrating on both conventional and cutting-edge life and health reinsurance offerings. Its operations are structured across five primary segments: the U.S. and Latin America, Canada, Europe, the Middle East and Africa (EMEA), Asia Pacific, and a distinct Corporate and Other division. The U.S. and Latin America segment is responsible for marketing individual and group life and health reinsurance to clients within its region, employing various agreement types such as yearly renewable term, coinsurance, and modified coinsurance.…
Historical context
All RZC earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FDS FactSet Research Systems Inc. | FY2026 Q4 · Calendar Q3 2026 | +3.9% | +3.8% | FactSet reports record FY26 results as AI and MCP adoption accelerate |
| PUK Prudential plc | FY2026 Q2 · Calendar Q3 2026 | -40.9% | -0.5% | Prudential sustains growth and capital returns focus in H1 2026 |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
| RY Royal Bank of Canada | FY2026 Q3 · Calendar Q3 2026 | +6.2% | -1.3% | RBC reports record Q3 earnings while investing for growth |
| AFRM Affirm Holdings, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1230.3% | +0.3% | Affirm's most profitable quarter shifts focus to product execution |
Latest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the RZC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:36:15.940040+00:00
- Polygon adjusted daily market bars · 2026-10-03T00:16:06.153823+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-03. For educational purposes only; not investment advice.